About Trinity Biotech
Trinity Biotech is a publicly listed company based in Bray (Ireland) founded in 1992. Provider of In vitro diagnostic kits for clinical labs. The company has 401 employees. Trinity Biotech has completed 3 acquisitions, including EpiCapture, Lab21 and iMMCO Diagnostics. Trinity Biotech offers products and services including Premier Resolution, Bartels FlexTrans Transport Medium, and Uni-Gold HIV Complete. Its focus areas include Diversified Diagnostics. Its legal entity is IMMCO DIAGNOSTICS, INC.
Company details
Trinity Biotech develops in vitro diagnostic kits for clinical labs. The company provides assay kits for infectious diseases, hematology, autoimmune diseases, critical care, urine tests and other assays based on clinical chemistry, In addition, it also provides rapid point-of-care assay kits for HIV, sexual health, respiratory infections, and a POC analyzer called Meritas that runs the assays. It also offers portable HbA1c analyzer.
- Headquarters Bray, Ireland
- Employees 401
- Stage Public
- SectorsHealthcare
- Website trinitybiotech.com
- Social LinkedIn
- Legal Name Trinity Biotech Plc Sponsored Adr Class A
- Annual Revenue$43.92 M (USD)-28.52as on Dec 31, 2025
- Net Profit-$37.49 M (USD)-18.15as on Dec 31, 2025
- EBITDA-$8.26 M (USD)14.45as on Dec 31, 2025
- Investors
- Employee Count401
- Investments & AcquisitionsEpiCapture
& 2 more
Products & Services of Trinity Biotech
Trinity Biotech offers a comprehensive portfolio of products and services, including Premier Resolution, Bartels FlexTrans Transport Medium, and Uni-Gold HIV Complete.
Device for detecting thalassemia and haemoglobin variants in diagnostics.
Medium to suppress contamination during specimen transport.
Test for rapid detection of HIV antibodies in blood samples.
Funding Insights of Trinity Biotech
- Total Rounds 2
- First Round $115M
(Apr 2015)
- Investors Count 1
All 2 funding rounds of Trinity Biotech with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Apr 2022 | Post-IPO | – | – | ||
| Apr 2015 | $115M | Post-IPO | – | – | – |
1 investors in total: 1 institutional.
Investors in Trinity Biotech
Trinity Biotech has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include MICO.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Manufacturer and supplier of brake systems and hydraulic components | 1946 | mico.com | Minneapolis, United States |
Investor details for Trinity Biotech
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of Trinity Biotech
58 people are tracked at Trinity Biotech (21 in leadership, 2 in board & advisors, 35 in team); the tracked headcount is 401.
| Name | Role | Group |
|---|---|---|
Ronan O’Caoimh | Chairman & CEO | Leadership |
John Gillard | CFO & Executive Director | Leadership |
Dennis Lefler | Director Of Operations | Leadership |
Kellern Wafula Mungami | Regional Director -eastern And North Africa | Leadership |
Bruce Marsh | Global Head Of Customer Service | Leadership |
Marlene Jinks | Director Of Marketing | Leadership |
Gary Keating | Chief Technology Officer | Leadership |
Colm Molloy Fcipd | Global Director Of Human Resources And Culture | Leadership |
Willem Pretorius | President Global HIV Sales & Marketing | Leadership |
Sameer Ahmed | General Manager - Canada. Director Of Sales Middle East & Africa | Leadership |
Brandon Stilb | Director Of Operations Autoimmune Division (immco) | Leadership |
Rasoul Yousefi | Head Of Algorithm Engineering | Leadership |
Paul Murphy | Group Head Of Financial Reporting | Leadership |
Adriana Cufaro | Head Of Finance Brazil | Leadership |
Avinash Kale | Director Program Management Office | Leadership |
Ana Paula Lopez | General Manager | Leadership |
Juliet Doran | Director Of Qa/ra | Leadership |
Matthew Wictome | Global Vice President Of Quality Assurance And Regulatory Affairs | Leadership |
Scott Dickinson | Global Director, Operations | Leadership |
Acca Ciarán Burke | Group Head Of Commercial Finance | Leadership |
38 more people are available in the full profile.
Complete people profiles for Trinity Biotech
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
IPO & Listings of Trinity Biotech
Trinity Biotech is a publicly listed company on the NASDAQ with ticker symbol TRIB in USA, operating in the Health technology sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
- IPO date23 Oct 1992
- Listed onNASDAQ: TRIB
- Listed entityTrinity Biotech Plc Sponsored ADR Class A
- Exchange sectorHealth technology
- ISINUS8964386036
- Share price$6.30 (-3.96% on the day) · 2026-10-13
- Market capitalisation$4.1M
- EPS (diluted, trailing year)$-52.93
- Volume (last session)18,731
Financials of Trinity Biotech
| Year | Revenue | Net income | EBITDA |
|---|---|---|---|
| 2025 | $43.9M | -$37.5M | -$8.3M |
| 2024 | $61.5M | -$31.7M | -$9.7M |
| 2023 | $56.9M | -$24.1M | -$13.5M |
| 2022 | $62.6M | -$41.0M | -$12.9M |
| 2021 | $92.8M | $873,630 | $10.5M |
Detailed financial statements for Trinity Biotech
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Trinity Biotech
Trinity Biotech has strategically engaged in corporate development activities, having acquired 3 companies. Notable acquisitions include EpiCapture, Lab21 and iMMCO Diagnostics.
| Company Name | Description | Domain | Location | Founded | Acquired | Amount |
|---|---|---|---|---|---|---|
Non-invasive liquid tests for cancer detection are developed. | epicapturedx.com | Dublin, Ireland | 2021 | Oct 2024 | $3M | |
Personalised diagnostic testing for diseases and predisposition is specialised in. | lab21.com | Cambridge, United Kingdom | 2005 | Oct 2013 | $7.53M | |
Diagnostic solutions for autoimmune disorders are developed and distributed. | immcodiagnostics.com | Buffalo, United States | 1971 | Jul 2013 | $32.75M |
Complete acquisition details for Trinity Biotech
Acquired stakes, deal sources and the complete acquisition history require an active premium plan.
- Acquired stakes
- Deal sources
- Complete history
- Exports
Verified entity values are shown only after access is granted.
Timeline of Trinity Biotech
7 dated milestones of Trinity Biotech across 32 years, from founding to its latest funding, stage changes and deals.
- Founded Trinity Biotech is founded.
- IPO Lists on the stock exchange (IPO).
- Acquisition Acquires iMMCO Diagnostics.
- Acquisition Acquires Lab21.
- Funding First funding round of $115.0M.
- Funding Latest funding round, Post-IPO,.
- Acquisition Acquires EpiCapture.
Web traffic of Trinity Biotech
The website of Trinity Biotech (trinitybiotech.com) receives about 9.3K visits a month.
- Monthly visits9.3K
▼ 2.5% vs previous month
Websites whose visitors overlap most with Trinity Biotech. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
| quidel.com | 100% | #5,902,749 | View details | ||
| focusdx.com | 98% | View details | |||
| topogen.com | 98% | 3.9K | #4,806,681 | View details | |
| oribiotech.com | 81% | 9.1K | #1,722,992 | View details | |
| chromadex.com | 65% | 8.7K | #2,570,549 | View details | |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
All 9 similar websites and full traffic analytics for Trinity Biotech
The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.
- 9 similar websites
- Audience overlap
- Engagement analytics
- Traffic by brand
Verified entity values are shown only after access is granted.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Trinity Biotech
Complete news archive for Trinity Biotech
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Trinity Biotech
Trinity Biotech was founded in 1992 and raised its 1st funding round 23 years after it was founded.
Trinity Biotech is headquartered in Bray, Ireland. It is registered at Bray, Wicklow, Ireland.
Trinity Biotech has 401 employees.
Annual revenue of Trinity Biotech is $43.92M as on Dec 31, 2025.
Trinity Biotech develops in vitro diagnostic kits for clinical labs. The company provides assay kits for infectious diseases, hematology, autoimmune diseases, critical care, urine tests and other assays based on clinical chemistry, In addition, it also provides rapid point-of-care assay kits for HIV, sexual health, respiratory infections, and a POC analyzer called Meritas that runs the assays. It also offers portable HbA1c analyzer.
Trinity Biotech offers Premier Resolution, Bartels FlexTrans Transport Medium, and Uni-Gold HIV Complete.
Yes, Trinity Biotech is publicly traded on NASDAQ under the ticker symbol TRIB.
Trinity Biotech has made 3 acquisitions, including EpiCapture, Lab21, and iMMCO Diagnostics.
Trinity Biotech has 1 investor. Key investors include MICO.
Trinity Biotech operates through Immco Diagnostics, Inc.